한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제22권3호
  • /
  • Pages.175-180
  • /
  • 2005
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지

개에서 키토산 비드를 이용한 cefadroxil 방출제어

Controlled Release of Cefadroxil from Chitosan Beads in Dogs

  • 김대근 (경북대학교 수의과대학 내과학교실) ;
  • 박승춘 (경북대학교 수의과대학 약리학교실) ;
  • 김태완 (경북대학교 수의과대학 생리학교실) ;
  • 이근우 (경북대학교 수의과대학 내과학교실) ;
  • 오태호 (경북대학교 수의과대학 내과학교실)
  • Kim Dae-Keun (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Kyungpook National University) ;
  • Park Seung-Chun (Department of Veterinary Pharmacology, College of Veterinary Medicine, Kyungpook National University) ;
  • Kim Tae-Wan (Department of Veterinary Physiology, College of Veterinary Medicine, Kyungpook National University) ;
  • Lee Keun-Woo (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Kyungpook National University) ;
  • Oh Tae-Ho (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Kyungpook National University)
  • 발행 : 2005.09.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

본 연구는 개에서 키토산 비드를 이용한 cefadroxil 방출에 영향을 주는 인자, 약물을 함유한 최적의 키토산 비드의 제조, 그리고 키토산 비드로부터 약물의 방출을 평가하는 것이다. 키토산 비드는 tripolyphosphate (TPP)와 이온결합으로 생성되며 비드의 크기는 1 mm 미만이었다. 비드로부터 cefadroxil 방출은 여러 인자에 영항을 받는다. TPP의 pH가 감소할수록 cefadroxil의 비드내 함유량은 증가하지만, 비드로부터 방출량은 감소한다. Cefadroxil의 방출속도은 TPP 농도가 증가할수록 감소한다. 결합시간이 길어지면, 방출량이 감소한다. Cefadroxil을 함유한 키토산 비드를 50 mg/kg 용량으로 건강한 개 4두의 피하에 이식한 결과, cefadroxil의 혈청내 농도는 1 ${\mu}g/ml$ 이상으로 7일간 유지되었다. 따라서 cefadroxil을 함유한 키토산 비드는 개의 농피증 치료에 유용한 것으로 사료되며 약물방출을 통제할 수 있는 약물수송체가 이용될 수 있다고 사료된다.

The purpose of this study is to investigate the effects of formulation variables on the release of cefadroxil form chitosan beads, to optimize the preparation of chitosan beads loaded with the drug for controlled release, and to evaluate the drug release form chitosan beads in dogs. Chitosan beads were prepared with tripolyphosphate (TPP) by ionic cross-linking and those sizes were less than 1 mm in diameter. The release behaviour of cefadroxil was affected various factors. As pH of TPP solutions decreased, the entrapment efficiency of cefadroxil increased, whereas the release of cefadroxil decreased. The release rate of cefadroxil form chitosan beads decreaed with the increased TPP solution concentration. When cross-linking time increased, the release of the drug from chitosan beads decreased. The cefadroxil loaded beads were implanted to 4 mixed breed dogs. The concentration of cefadroxil in sera due to chitosan beads implanted with 50 mg/kg body weight of beads was sustained more than 1 ug/ml for the whole 7 days period. Therefore, the cefadroxil loaded beads can be used successfully in pyoderma of dogs. These results indicate that chitosan beads may become a potential delivery system to control the release of drug.

키워드

참고문헌

  1. Alsarra IA, Neau SH, Howard MA. Effects of preparative parameters on the properties of chitosan hydrogel beads containing Candida rugosa lipase. Biomaterials 2004; 25: 2645-2655 https://doi.org/10.1016/j.biomaterials.2003.09.051
  2. Angarano DW, MacDonald JM. Efficacy of bacterial dermatitis In dogs. J Am Vet Med Assoc 1989; 194: 57-59
  3. Bodmeier R, Oh KH, Pramar Y. Preparation and evaluation of drug-containing chitosan beads. Drug Develop Indus Pharm 1989; 15: 1475-1494 https://doi.org/10.3109/03639048909062758
  4. Campbell BG, Rosin E. Effect of food on absorption of cefadroxil and cephalexin in dogs. J Vet Pharmcol Ther 1998; 21: 418-420 https://doi.org/10.1046/j.1365-2885.1998.00163.x
  5. Crosse R, Burt DG. Antibiotic concentration in the serum of dogs and cats following a single oral dose of cephalexin. Vet Rec 1984; 115:106-107 https://doi.org/10.1136/vr.115.5.106
  6. Frank LA, Kunkle GA. Comparison of the efficacy of cefadroxil and generic and proprietary cephalexin in the treatment of pyoderma in dogs. J Am Vet Med Assoc 1993; 203: 530-533
  7. Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm 2002; 239: 165-174
  8. Ko JA, Park HJ, Park YS, Hwang SJ, Park JB. Chitosan rnicroparticle preparation for controlled drug release by response surface methodology. J Microencapsul 2003; 20: 791-797 https://doi.org/10.1080/02652040310001600514
  9. Kweon DK, Song SB, Park YY. Preparation of water-soluble chitosan/heparin complex and its application as wound healing accelerator. Biomaterials 2003; 23: 1595-1601
  10. Lorian V. Antibiotics in laboratory medicine. 4th ed. Williams & Wilkins. 1996; 234-246
  11. Malettas WG, Quingley HJ, Adickes ED. in: R.A.A. Muzzarelli (Ed.), Chitin in Nature and Technology. New York: Plenum press, 1986; 435
  12. Mi FL, Shyu SS, Kuan CY, Lee ST, Lu KT, Jang SF. Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. I. Enzymatic hydrolysis of polymer. J Appl Polym Sci 1999a; 74: 1868-1879 https://doi.org/10.1002/(SICI)1097-4628(19991114)74:7<1868::AID-APP32>3.0.CO;2-N
  13. Minami S, Masuda M, Suzuki H, Okamoto Y, Matsuhashi A, Kato K, Shigenasa Y. Subcutaneous injected chitosan induces systemic activation in dogs. Carbohydrate Polymers 1997; 33: 285-294 https://doi.org/10.1016/S0144-8617(97)00024-6
  14. Nakanomyo H, Imai K, Hiraoka M, Hasegawa Y. Microbiological assay method of cefadroxil in biological specimens. Jpn J Antibiot 1980; 33: 767-772 https://doi.org/10.7164/antibiotics.33.767
  15. Plumb DC. Vetrinary drug handbook. 4th ed. Minnesota, Iowa state press. 2002; 132-134
  16. Ravi Kumar MNV. A review of chitin and chitosan applications. React Funct Polym 2000; 46: 1-27 https://doi.org/10.1016/S1381-5148(00)00038-9
  17. Remunan-Lopez C, Bodmeier R. Mechanical, water uptake and permeability properties of cross-linked chitosan glutamate and alginate films. J Contrl Release 1997; 44: 215-225 https://doi.org/10.1016/S0168-3659(96)01525-8
  18. Rhee SJ, Park YJ, Lee SJ, Chung CP. Fabrication and characterization of flurbipofen leaded chitosan beads for periodontal regeneration. J Kor Pharm Sci 1997; 27: 71-77
  19. Sashiwa H, Aiba SI. Chemically modified chitin and chitosan as biomaterials. Prog Polym Sci 2004; 29: 887-908 https://doi.org/10.1016/j.progpolymsci.2004.04.001
  20. Scott DW, Miller WH, Griffin CE. Small amimal dermatology. 6th ed. Philadephia: WB Saunders. 2001; 275-278
  21. Sezer AD, Akbuga J. Controlled release of piroxicam from chitosan beads. Int J Pharm 1995; 121: 113-116 https://doi.org/10.1016/0378-5173(94)00413-Y
  22. Shiraishi S, Imai T, Otagiri M. Controlled release of indomethacin by chitosan-poluelectrolyte complex: opitmization and in vivo/in vitro evaluation. J Control Release 1993; 25: 217-225 https://doi.org/10.1016/0168-3659(93)90080-O
  23. Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int J Pharm 2002; 233: 217-225 https://doi.org/10.1016/S0378-5173(01)00943-7
  24. Shu XZ, Zhu KJ. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Euro J Pharm Biopharm 2002; 54: 235-243 https://doi.org/10.1016/S0939-6411(02)00052-8
  25. Shu xz, Zhu KJ. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int J Pharm 2000; 201: 51-58 https://doi.org/10.1016/S0378-5173(00)00403-8
  26. Yusof NLM, Lim LY, Khor E. Preparation and characterization of chitin beads as a wound dressing precursor. J Biomed Mater Res 2001; 54: 59-68 https://doi.org/10.1002/1097-4636(200101)54:1<59::AID-JBM7>3.0.CO;2-U